218 related articles for article (PubMed ID: 36010584)
41. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
Basisty N; Kale A; Patel S; Campisi J; Schilling B
Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
[TBL] [Abstract][Full Text] [Related]
42. Targeting cellular senescence prevents age-related bone loss in mice.
Farr JN; Xu M; Weivoda MM; Monroe DG; Fraser DG; Onken JL; Negley BA; Sfeir JG; Ogrodnik MB; Hachfeld CM; LeBrasseur NK; Drake MT; Pignolo RJ; Pirtskhalava T; Tchkonia T; Oursler MJ; Kirkland JL; Khosla S
Nat Med; 2017 Sep; 23(9):1072-1079. PubMed ID: 28825716
[TBL] [Abstract][Full Text] [Related]
43. α-Fucosidase as a novel convenient biomarker for cellular senescence.
Hildebrand DG; Lehle S; Borst A; Haferkamp S; Essmann F; Schulze-Osthoff K
Cell Cycle; 2013 Jun; 12(12):1922-7. PubMed ID: 23673343
[TBL] [Abstract][Full Text] [Related]
44. The Tocotrienol-Rich Fraction Is Superior to Tocopherol in Promoting Myogenic Differentiation in the Prevention of Replicative Senescence of Myoblasts.
Khor SC; Razak AM; Wan Ngah WZ; Mohd Yusof YA; Abdul Karim N; Makpol S
PLoS One; 2016; 11(2):e0149265. PubMed ID: 26885980
[TBL] [Abstract][Full Text] [Related]
45. Expression profile of senescence-associated beta-galactosidase and activation of telomerase in human ovarian surface epithelial cells undergoing immortalization.
Litaker JR; Pan J; Cheung Y; Zhang DK; Liu Y; Wong SC; Wan TS; Tsao SW
Int J Oncol; 1998 Nov; 13(5):951-6. PubMed ID: 9772284
[TBL] [Abstract][Full Text] [Related]
46. Techniques to Induce and Quantify Cellular Senescence.
Noren Hooten N; Evans MK
J Vis Exp; 2017 May; (123):. PubMed ID: 28518126
[TBL] [Abstract][Full Text] [Related]
47. A progressive reduction in autophagic capacity contributes to induction of replicative senescence in Hs68 cells.
Han BI; Hwang SH; Lee M
Int J Biochem Cell Biol; 2017 Nov; 92():18-25. PubMed ID: 28918366
[TBL] [Abstract][Full Text] [Related]
48. Identification of SYK inhibitor, R406 as a novel senolytic agent.
Cho HJ; Yang EJ; Park JT; Kim JR; Kim EC; Jung KJ; Park SC; Lee YS
Aging (Albany NY); 2020 May; 12(9):8221-8240. PubMed ID: 32379705
[TBL] [Abstract][Full Text] [Related]
49. Detection of Senescence Markers During Mammalian Embryonic Development.
Storer M; Keyes WM
Methods Mol Biol; 2017; 1534():199-210. PubMed ID: 27812881
[TBL] [Abstract][Full Text] [Related]
50. A versatile method for the identification of senolytic compounds.
Annunziata C; Castoldi F; Jan S; Ang HX; Ristovska M; Melini S; Welch R; Riedel CG; Pietrocola F
Cell Stress; 2023 Dec; 7(12):105-111. PubMed ID: 38145234
[TBL] [Abstract][Full Text] [Related]
51. IGFBP-3 plays an important role in senescence as an aging marker.
Hong S; Kim MM
Environ Toxicol Pharmacol; 2018 Apr; 59():138-145. PubMed ID: 29579543
[TBL] [Abstract][Full Text] [Related]
52. Detection of senescence using machine learning algorithms based on nuclear features.
Duran I; Pombo J; Sun B; Gallage S; Kudo H; McHugh D; Bousset L; Barragan Avila JE; Forlano R; Manousou P; Heikenwalder M; Withers DJ; Vernia S; Goldin RD; Gil J
Nat Commun; 2024 Feb; 15(1):1041. PubMed ID: 38310113
[TBL] [Abstract][Full Text] [Related]
53. Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells.
As Sobeai HM; Alohaydib M; Alhoshani AR; Alhazzani K; Almutairi MM; Saleh T; Gewirtz DA; Alotiabi MR
Saudi Pharm J; 2022 Jan; 30(1):91-101. PubMed ID: 35145348
[TBL] [Abstract][Full Text] [Related]
54. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
55. Multi-pronged approach to human mesenchymal stromal cells senescence quantification with a focus on label-free methods.
Zhai W; Tan J; Russell T; Chen S; McGonagle D; Win Naing M; Yong D; Jones E
Sci Rep; 2021 Jan; 11(1):1054. PubMed ID: 33441693
[TBL] [Abstract][Full Text] [Related]
56. [Sorting of senescent cells by flow cytometry: Specificities and pitfalls to avoid].
Rodzinski É; Martin N; Rouget R; Pioger A; Dehennaut V; Molendi-Coste O; Dombrowicz D; Goy E; de Launoit Y; Abbadie C
Med Sci (Paris); 2024 Mar; 40(3):275-282. PubMed ID: 38520103
[TBL] [Abstract][Full Text] [Related]
57. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss.
Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ
J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351
[TBL] [Abstract][Full Text] [Related]
58. Characterization of cellular senescence in doxorubicin-induced aging mice.
Sun T; Zhang L; Feng J; Bao L; Wang J; Song Z; Mao Z; Li J; Hu Z
Exp Gerontol; 2022 Jun; 163():111800. PubMed ID: 35398171
[TBL] [Abstract][Full Text] [Related]
59. Cellular Senescence: A Translational Perspective.
Kirkland JL; Tchkonia T
EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
[TBL] [Abstract][Full Text] [Related]
60. A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells.
Magkouta S; Veroutis D; Pousias A; Papaspyropoulos A; Pippa N; Lougiakis N; Kambas K; Lagopati N; Polyzou A; Georgiou M; Chountoulesi M; Pispas S; Foutadakis S; Pouli N; Marakos P; Kotsinas A; Verginis P; Valakos D; Mizi A; Papantonis A; Vatsellas G; Galanos P; Bartek J; Petty R; Serrano M; Thanos D; Roussos C; Demaria M; Evangelou K; Gorgoulis VG
Mol Cell; 2023 Oct; 83(19):3558-3573.e7. PubMed ID: 37802028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
